{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:05:42Z","timestamp":1792098342514,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.bone.2006.06.022","type":"journal-article","created":{"date-parts":[[2006,9,2]],"date-time":"2006-09-02T07:55:59Z","timestamp":1157183759000},"page":"175-181","source":"Crossref","is-referenced-by-count":50,"title":["No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women"],"prefix":"10.1016","volume":"40","author":[{"given":"T.","family":"Ueland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bollerslev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.G.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.M.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.M.A.","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.H.","family":"Mullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.L.","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2006.06.022_bib1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI113125","article-title":"Genetic determinants of bone mass in adults. A twin study","volume":"80","author":"Pocock","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2006.06.022_bib2","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/jbmr.5650081010","article-title":"Long-term fracture prediction by bone mineral assessed at different skeletal sites","volume":"8","author":"Melton","year":"1993","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.06.022_bib3","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1210\/jc.2002-021063","article-title":"Osteoprotegerin gene polymorphism and the risk of osteoporosis and vascular disease","volume":"87","author":"Hofbauer","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2006.06.022_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s001090100226","article-title":"Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology","volume":"79","author":"Hofbauer","year":"2001","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bone.2006.06.022_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bone.2006.06.022_bib6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/bbrc.1999.0252","article-title":"A new member of tumor necrosis factor ligand family, ODF\/OPGL\/TRANCE\/RANKL, regulates osteoclast differentiation and function","volume":"256","author":"Takahashi","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2006.06.022_bib7","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2006.06.022_bib8","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.130200197","article-title":"Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression","volume":"97","author":"Shevde","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2006.06.022_bib9","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1074\/jbc.M010764200","article-title":"Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation","volume":"276","author":"Srivastava","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2006.06.022_bib10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1432-1327.1998.2540685.x","article-title":"Cloning and characterization of the gene encoding human osteoprotegerin\/osteoclastogenesis-inhibitory factor","volume":"254","author":"Morinaga","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bone.2006.06.022_bib11","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1210\/jc.2002-020124","article-title":"Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis","volume":"87","author":"Arko","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2006.06.022_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00774-003-0461-3","article-title":"Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios","volume":"22","author":"Jorgensen","year":"2004","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2006.06.022_bib13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1359\/jbmr.2002.17.7.1245","article-title":"Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures","volume":"17","author":"Langdahl","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.06.022_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1096-7192(03)00125-2","article-title":"Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men","volume":"80","author":"Yamada","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bone.2006.06.022_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00223-002-0066-1","article-title":"Calcium-sensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density, calcaneal ultrasound indices, or fracture rate in a large cohort of elderly women","volume":"74","author":"Bollerslev","year":"2004","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2006.06.022_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S8756-3282(02)00851-7","article-title":"Apolipoprotein E4 is associated with reduced calcaneal quantitative ultrasound measurements and bone mineral density in elderly women","volume":"31","author":"Dick","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2006.06.022_bib17","first-page":"19","article-title":"Development of the Melbourne FFQ: a food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort","volume":"1","author":"Ireland","year":"1994","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"10.1016\/j.bone.2006.06.022_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1530\/eje.0.1450685","article-title":"Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess\u2014Possible role in bone homeostasis","volume":"145","author":"Ueland","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bone.2006.06.022_bib19","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1073\/pnas.77.4.2234","article-title":"Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma","volume":"77","author":"Price","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2006.06.022_bib20","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/jbmr.5650110817","article-title":"Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links","volume":"11","author":"Randall","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.06.022_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF01623275","article-title":"The assessment of vertebral deformity: a method for use in population studies and clinical trials","volume":"3","author":"McCloskey","year":"1993","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2006.06.022_bib22","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/rcm.1038","article-title":"A standard protocol for single nucleotide primer extension in the human genome using matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry","volume":"17","author":"Wise","year":"2003","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.bone.2006.06.022_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/gepi.10252","article-title":"Pedigree disequilibrium tests for multilocus haplotypes","volume":"25","author":"Dudbridge","year":"2003","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.bone.2006.06.022_bib24","unstructured":"K.W. Carter, P.A. McCaskie, L.J. Palmer, JLIN: a Java based Linkage Disequilibrium plotter. [online] http:\/\/www.genepi.org.au\/projects\/jlin_2004."},{"key":"10.1016\/j.bone.2006.06.022_bib25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","article-title":"Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis","volume":"14","author":"Yano","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.06.022_bib26","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1210\/jc.2002-020977","article-title":"Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study","volume":"88","author":"Ueland","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2006.06.022_bib27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/jc.86.2.631","article-title":"Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women","volume":"86","author":"Browner","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2006.06.022_bib28","doi-asserted-by":"crossref","first-page":"57S","DOI":"10.1016\/8756-3282(95)00381-9","article-title":"Epidemiology of hip fractures","volume":"18","author":"Kannus","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.bone.2006.06.022_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0006-291X(02)00137-7","article-title":"A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function","volume":"293","author":"Brandstrom","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2006.06.022_bib30","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1210\/jc.2003-032054","article-title":"Osteoprotegerin gene polymorphisms in men with coronary artery disease","volume":"89","author":"Soufi","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2006.06.022_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00223-001-2081-z","article-title":"Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population","volume":"71","author":"Wynne","year":"2002","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2006.06.022_bib32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s100380200058","article-title":"Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis","volume":"47","author":"Ohmori","year":"2002","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bone.2006.06.022_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00223-002-2136-9","article-title":"Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women","volume":"74","author":"Brandstrom","year":"2004","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2006.06.022_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0895-4356(03)00011-8","article-title":"Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology","volume":"56","author":"Attia","year":"2003","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.bone.2006.06.022_bib35","first-page":"631","article-title":"Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women","volume":"86","author":"Browner","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2006.06.022_bib36","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bone.2004.12.015","article-title":"Circulating amounts of osteoprotegerin and RANK ligand: genetic influence and relationship with BMD assessed in female twins","volume":"36","author":"Abrahamsen","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2006.06.022_bib37","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1210\/jc.2002-020396","article-title":"Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women","volume":"87","author":"Rogers","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2006.06.022_bib38","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s00198-005-1844-1","article-title":"The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women","volume":"38","author":"Mezquita-Raya","year":"2005","journal-title":"Osteoporos. Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328206005813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328206005813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T11:23:24Z","timestamp":1547378604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328206005813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S8756328206005813"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2006.06.022","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}